William G. Rice is CEO & Chairman +1 at Aptose Biosciences Inc. (APTO). They have made 12 open-market trades across 1 company since 2019, most recently 2024-11-25.
CIK 0001761487
11 open-market purchases totalling $193K since 2019, against 1 sale. Across 11 scored buys the stock is up 7.3% at ninety days, and 6.4 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| APTO | 613,252 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2024-11-26 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 64% | 45% | 36% |
| Avg Move | +0.2% | +0.2% | +7.3% |
| Alpha | +0.1% | -1.3% | +6.4% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APTO | BUY | 2024-11-25 | 2024-11-26 | $0.20 | $20K | +6.6% | +31.9% | -24.3% |
| APTO | BUY | 2022-09-19 | 2022-09-21 | $0.68 | $7K | -4.7% | -21.3% | -24.2% |
| APTO | BUY | 2022-06-06 | 2022-06-06 | $0.97 | $10K | -18.5% | -14.6% | -19.8% |
| APTO | BUY | 2021-12-16 | 2021-12-17 | $1.52 | $20K | +0.7% | -8.6% | -17.9% |
| APTO | BUY | 2021-12-15 | 2021-12-15 | $1.12 | $20K | +12.3% | +9.8% | -13.1% |
| APTO | BUY | 2021-11-26 | 2021-11-29 | $2.31 | $20K | -8.2% | -38.4% | -45.2% |
| APTO | BUY | 2021-07-02 | 2021-07-06 | $3.29 | $20K | -12.8% | -20.4% | -32.0% |
| APTO | SELL | 2020-07-10 | 2020-07-10 | $6.05 | $2.0M | -11.1% | -17.9% | -1.2% |
| APTO | BUY | 2020-03-25 | 2020-03-26 | $5.82 | $20K | +4.2% | +24.2% | +11.7% |
| APTO | BUY | 2019-10-24 | 2019-10-28 | $1.92 | $19K | +13.2% | +31.6% | +170.8% |
| APTO | BUY | 2019-04-18 | 2019-04-19 | $1.85 | $19K | +6.6% | +12.0% | +61.7% |
| APTO | BUY | 2019-03-14 | 2019-03-15 | $1.90 | $19K | +2.5% | -4.1% | +12.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.